KASUGA Kensaku

カスガケンサク | KASUGA Kensaku

Affiliation and department：
Job title：助教
Homepage URL (1)： http://kaken.nii.ac.jp/d/r/70547546.ja.html

Research field (1)： Neurology

Research keywords (7)： Alzheimer's disease , Fluid biomarker , バイオマーカー , インスリンシグナル , βアミロイド , リン酸化タウ , アルツハイマー病

Research theme for competitive and other funds (8)：

2019 - 2022 Alzheimer's disease related biomarkers in progressive supranuclear palsy
2018 - 2020 プリオン病の早期診断基準の作成を目指した新たなエビデンス創出とその検証に用いる遺伝性プリオン病未発症例の臨床調査と画像・生体材料の収集
2016 - 2019 Neuronal activity affects AD pathophysiology
2017 - 2019 血液バイオマーカーを用いた認知症と精神・神経疾患の簡易鑑別診断システムの構築
2015 - 2018 Amino acid profile in plasma of Alzheimer's disease

Show all

Papers (125)：

Toshiaki Nonaka, Ryusuke Ae, Koki Kosami, Hiroya Tange, Miho Kaneko, Takehiro Nakagaki, Tsuyoshi Hamaguchi, Nobuo Sanjo, Yosikazu Nakamura, Tetsuyuki Kitamoto, et al. A Retrospective Cohort Study of a Newly Proposed Criteria for Sporadic Creutzfeldt-Jakob Disease. Diagnostics. 2024
Takanobu Ishiguro, Kensaku Kasuga. Alzheimer’s Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy. Brain Sciences. 2024
Eric McDade, Haiyan Liu, Quoc Bui, Jason Hassenstab, Brian Gordon, Tammie Benzinger, Yuanyuan Shen, Jigyasha Timsina, Lihua Wang, Yun Ju Sung, et al. Ubiquitin-Proteasome System in the Different Stages of Dominantly Inherited Alzheimer's Disease. Research square. 2024
Yoshiki Niimi, Shorena Janelidze, Kenichiro Sato, Naoki Tomita, Tadashi Tsukamoto, Takashi Kato, Kenji Yoshiyama, Hisatomo Kowa, Atsushi Iwata, Ryoko Ihara, et al. Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly. Alzheimer's research & therapy. 2024. 16. 1. 115-115
渡邊裕美, 平尾嘉利, 春日健作, 北村香織, 中村和利, 山本格. 尿中急性期タンパク質(Acute Phase Proteins)の変動による認知症予測の可能性. 日本衛生学雑誌. 2024. 79. Suppl. S266-S266

ｍore...

MISC (118)：

石黒敬信, 春日健作, 渡邉緑, 木下悠紀子, 月江珠緒, 小野寺理, 池内健. 進行性核上性麻痺における脳脊髄液AT(N)バイオマーカーと臨床像. 日本神経学会学術大会プログラム・抄録集. 2024. 65th
徳武孝允, 春日健作, 月江珠緒, 石黒敬信, 五十嵐一也, 小野寺理, 池内健. 脳アミロイドアンギオパチー関連炎症での脳脊髄液バイオマーカーの解析. 日本神経学会学術大会プログラム・抄録集. 2024. 65th
竹野下尚仁, 春日健作, 春日健作, 池内健, 石井賢二, 清水聰一郎, 小林良太, 川勝忍, 金田大太, 松田実. この症例をどう診るか-今,診断バイオマーカーの意義を再考する-症例検討. 老年精神医学雑誌. 2024. 35
金澤雅人, 春日健作, 島田斉, 池内健, 小野寺理. Development of novel disease-modifying therapies against progressive supranuclear palsy -How to conduct successful clinical trials-. 神経治療学(Web). 2023. 40. 3
石黒敬信, 今野卓哉, 原範和, 朱斌, 岡田聡, 柴田護, 雑賀玲子, 北野貴也, 祢津智久, 浜由香, et al. CSF1R関連白質脳症:部分欠失を含む新規CSF1R変異の同定と臨床・画像的特徴. 日本神経学会学術大会プログラム・抄録集. 2023. 64th

ｍore...

Books (1)：

Lectures and oral presentations (12)：

Progress pattern of Alzheimer’s disease based on longitudinal changes of CSF biomarkers
(62nd Annual Meeting of the Japanese Society of Neurology 2021)
CSF and blood biomarkers for PSP
(62nd Annual Meeting of the Japanese Society of Neurology 2021)
脳脊髄液バイオマーカーの縦断的変化から考察するアルツハイマー病態の進展
(The 39th Annual Meeting of Japan Society for Dementia Research 2020)
CSFバイオマーカーによるSNAPの再考
(The 38th Annual Meeting of Japan Society for Dementia Research 2019)
ディベートセッション:認知症は告知すべき
(The 38th Annual Meeting of Japan Society for Dementia Research 2019)

ｍore...

Education (2)：

Professional career (1)：

Work history (6)：

2018/04 - 現在 Brain Research Institute, Niigata University Department of Molecular Genetics Assistant Professor
2017/04 - 2018/03 Brain Research Institute, Niigata University Department of Molecular Genetics Contract Assistant Professor
2014/04 - 2017/03 Institute for Research Promotion, Niigata University Center for Transdisciplinary Research Assistant Professor
2012/10 - 2014/03 Niigata University Medical & Dental Hospital Department of Neurology Contract Assistant Professor
2010/04 - 2012/09 University of California, San Diego Department of Neurosciences Post doctoral fellow

Show all

Committee career (1)：

Awards (1)：

Association Membership(s) (5)：

Alzheimer's Association , THE JAPANESE SOCIETY OF INTERNAL MEDICINE , 日本神経治療学会 , JAPANESE SOCIETY OF NEUROLOGY , JAPAN SOCIETY FOR DEMENTIA RESEARCH

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page